Curtis N. Rambaran
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Phase 1 Study Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Zerlasiran in Japanese Participants.
Journal: Journal of atherosclerosis and thrombosis
Published: May 10, 2026
Zerlasiran-A Small-Interfering RNA Targeting Lipoprotein(a): A Phase 2 Randomized Clinical Trial.
Journal: JAMA
Published: November 18, 2024
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a): A Randomized Clinical Trial.
Journal: JAMA
Published: April 08, 2024
Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
Journal: JAMA
Published: April 03, 2022
Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the Week.
Journal: Journal of the American College of Cardiology
Published: January 25, 2021
NaPi-IIb Inhibition for Hyperphosphatemia in CKD Hemodialysis Patients.
Journal: Kidney international reports
Published: September 30, 2020
Safety and Pharmacokinetics of DS-1040 Drug-Drug Interactions With Aspirin, Clopidogrel, and Enoxaparin.
Journal: Journal of clinical pharmacology
Published: October 01, 2019
Randomized trial of allergen-induced asthmatic response in smokers and non-smokers: effects of inhaled corticosteroids.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: January 28, 2015
Assessment of Risk in Chronic Airways Disease Evaluation (ARCADE): Protocol and preliminary data.
Journal: Chronic respiratory disease
Published: August 28, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026